104 results
Page 4 of 6
8-K
EX-99.1
arog jf96dwr5vne
27 Jan 22
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Corporate Update
4:07pm
8-K
EX-99.2
dksf9dco e0qz
10 Jan 22
Other Events
7:11am
8-K
EX-99.1
qzc3bi 4zhdc3
10 Jan 22
Other Events
7:11am
8-K
EX-99.2
ud27tlgnlq7hq
27 Oct 21
Other Events
7:01am
8-K
EX-99.1
axkbrs3uxx5ijfvuo8
27 Oct 21
Other Events
7:01am
8-K
EX-99.1
o7olh0vg8c76ub345zf
14 Oct 21
Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
5:10pm
8-K
EX-99.1
byxjlvu
30 Sep 21
Nurix Therapeutics Expands its Board of Directors with the Addition of Two Industry Leaders
7:08am
S-3ASR
EX-1.2
h23x3n
4 Aug 21
Automatic shelf registration
4:11pm
S-3ASR
oejpr5b
4 Aug 21
Automatic shelf registration
4:11pm
8-K
EX-99.1
ovfacd5rjn266w523
13 Jul 21
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
4:12pm
8-K
EX-99.1
kllg 1hfgb
2 Jun 21
Regulation FD Disclosure
7:00am
8-K
EX-99.1
5mi5hn8h
1 Jun 21
Nurix Therapeutics Appoints Industry Leader Clay Siegall, Ph.D., to its
4:11pm
8-K
EX-99.1
ekvea8
13 Apr 21
Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
4:08pm
424B4
hkb43ey3clh5odk
5 Mar 21
Prospectus supplement with pricing info
4:07pm